Michael William Lark

Trevena, Inc.

$10,992,682

Attributed

$12,543,962

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.2M · FY2009–25

$5M$3.8M$2.5M$1.3M$0

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$12,543,962 · 4

By mechanism

RC2$7,639,642 · 1

UG3$3,102,560 · 1

R42$1,463,597 · 1

U01$338,163 · 1

Top collaborators

James E Zadina1 shared

Others in their field

Top investigators on “In Vivo”

David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
Dennis R. Burton · Scripps Research Institute$212,708,174
Mark S Klempner · Tufts Medical Center$128,021,180
Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200

Research focus

In VivoDesignSafetyIn VitroAnalgesicsNovel TherapeuticsClinical TrialsPharmaceutical PreparationsReceptorDrug KineticsMedicalReceptor SignalingLigandsAgonistResponseAffectChemistryAdverse EffectsBiologyFosteringBaseLeadReceptor ActivationScreening Procedure